Thymosin Beta-4 vs Tri-Heal — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Thymosin Beta-4 (TB-4) is the full-length 43-amino acid actin-sequestering peptide from which the commonly used research fragment TB-500 (residues 17-23, LKKTETQ) is derived. TB-4 is the most abundant thymosin-family protein in virtually all mammalian cells, where it maintains th...
Calculate Thymosin Beta-4 dose →Tri-Heal is a vendor healing peptide blend combining TB-500 (25 mg), BPC-157 (10 mg), and KPV (10 mg) - three peptides with complementary tissue repair and anti-inflammatory mechanisms. TB-500 provides systemic tissue repair and anti-fibrotic activity via actin polymerization and...
Calculate Tri-Heal dose →| Parameter | Thymosin Beta-4 | Tri-Heal |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Vendor Blend |
| Half-Life | ~30-60 min (plasma) | - |
| Typical Dose | 1.5-2.5 mg, 2-3x/week | - |
| Frequency | 2-3 times per week | - |
| Route | Subcutaneous, IV, Topical, Intranasal | Subcutaneous |
| FDA Status | Phase II | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.